HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroprevalence and risk factors for hepatitis A among Montreal street youth.

AbstractOBJECTIVE:
To estimate the prevalence of hepatitis A virus (HAV) antibodies among Montreal street youth.
METHOD:
Anti-HAV antibody testing was performed on blood samples from a hepatitis B and C study conducted among street youth in 1995-96.
RESULTS:
Among the 427 youth aged 14 to 25 years, prevalence of HAV antibodies was 4.7% (95% confidence interval [CI]: 2.9%-7.2%). A multivariate logistic regression analysis showed that birth in a country with a high anti-HAV prevalence (Adjusted odds ratio [AOR]: 200.7; 95% CI: 38.1-1058.4), having had sexual partner(s) with history of unspecified hepatitis (AOR: 13.8; 95% CI: 4.2-45.2), and insertive anal penetration (AOR: 5.1; 95% CI: 1.6-16.7) were independently associated with infection.
CONCLUSION:
Based on the relatively low HAV prevalence, the high prevalence of risk factors for infection, and the substantial hepatitis B and C prevalence, vaccination against hepatitis A is now actively promoted among Montreal street youth.
AuthorsElise Roy, Nancy Haley, Pascale Leclerc, Lyne Cédras, Lucie Bédard, Robert Allard
JournalCanadian journal of public health = Revue canadienne de sante publique (Can J Public Health) 2002 Jan-Feb Vol. 93 Issue 1 Pg. 52-3 ISSN: 0008-4263 [Print] Switzerland
PMID11925701 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatitis Antibodies
Topics
  • Adolescent
  • Adult
  • Female
  • Hepatitis A (diagnosis, epidemiology, transmission)
  • Hepatitis Antibodies (blood)
  • Homeless Youth (statistics & numerical data)
  • Humans
  • Male
  • Quebec (epidemiology)
  • Risk Factors
  • Seroepidemiologic Studies
  • Sexual Behavior
  • Surveys and Questionnaires
  • Urban Population

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: